Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-23

Clinical Trial Update: TRICuspid Intervention in Heart Failure Trial [NA]

View source ↗

Summary

Sponsor LMU Klinikum reports that the TRICuspid Intervention in Heart Failure Trial is active but not currently recruiting for heart failure attributable to sev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: LMU Klinikum | Conditions: Heart Failure Attributable to Severe Tricuspid Regurgitation | NA | Status: ACTIVE_NOT_RECRUITING